Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients.

Expiratory flow limitation (EFL), which promotes dynamic hyperinflation and increased work of breathing, often occurs in chronic obstructive pulmonary disease (COPD). The purpose of this study was to assess the effect of bronchodilators on EFL and end-expiratory lung volume in patients with moderate-to-severe COPD. EFL was assessed by applying negative expiratory pressure (NEP) at the mouth during tidal expiration. EFL was present when expiratory flow did not increase or increased only in the early phase of expiration with NEP. In 18 patients (age 65+/-2 yrs; forced expiratory volume in one second (FEV1)=45+/-4% predicted) pulmonary function tests and a series of NEP (-3.5 cmH2O) test breaths were performed at rest in a sitting position before and 20 min after inhalation of 400 microg of salbutamol. EFL was detected in 11 patients and persisted after salbutamol in all of these flow-limited (FL) patients. After bronchodilator administration FL patients exhibited a significant decrease in functional residual capacity (FRC) associated with an increase in inspiratory capacity (IC). In contrast, no changes in FRC and IC were observed in the seven non flow-limited (NFL) patients after administration of salbutamol. Except for one NFL patient, the other 17 patients (six NFL and 11 FL) had no reversibility of their bronchial obstruction (delta FEV1 <10% pred). In conclusion, patients with chronic obstructive pulmonary disease and expiratory flow limitation, even if nonresponders in terms of forced expiratory volume in one second, may benefit from bronchodilators because they can breathe, still in a flow-limited manner, at a lower lung volume.

[1]  Y. P. Adams,et al.  MECHANISMS AND MANAGEMENT , 1998 .

[2]  M. Pichot,et al.  Expiratory flow limitation in stable asthmatic patients during resting breathing. , 1997, American journal of respiratory and critical care medicine.

[3]  M. Pichot,et al.  Expiratory flow limitation in COPD patients after single lung transplantation. , 1997, American journal of respiratory and critical care medicine.

[4]  R. Pellegrino,et al.  Lung hyperinflation and flow limitation in chronic airway obstruction. , 1997, The European respiratory journal.

[5]  M. Becklake,et al.  Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[6]  J C Yernault,et al.  Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.

[7]  N. Koulouris,et al.  A simple method to detect expiratory flow limitation during spontaneous breathing. , 1995, The European respiratory journal.

[8]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[9]  E. d’Angelo,et al.  Dependence of maximal flow-volume curves on time course of preceding inspiration in patients with chronic obstruction pulmonary disease. , 1994, American journal of respiratory and critical care medicine.

[10]  N. Koulouris,et al.  Detection of expiratory flow limitation during mechanical ventilation. , 1994, American journal of respiratory and critical care medicine.

[11]  D. O’Donnell,et al.  Breathlessness in patients with chronic airflow limitation. Mechanisms and management. , 1994, Chest.

[12]  D. O’Donnell,et al.  Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. , 1993, The American review of respiratory disease.

[13]  N. Eissa,et al.  Partitioning of work of breathing in mechanically ventilated COPD patients. , 1993, Journal of applied physiology.

[14]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[15]  A. Miller,et al.  Lung function testing: selection of reference values and interpretative strategies. , 1992, The American review of respiratory disease.

[16]  A. Harf.  How to express the reversibility of bronchial obstruction? , 1992, The European respiratory journal.

[17]  J. Earis,et al.  Acute bronchodilator trials in chronic obstructive pulmonary disease. , 1992, The American review of respiratory disease.

[18]  C. van Weel,et al.  A comparison of six different ways of expressing the bronchodilating response in asthma and COPD; reproducibility and dependence of prebronchodilator FEV1. , 1992, The European respiratory journal.

[19]  P. Sherwood Burge,et al.  Measures of reversibility in response to bronchodilators in chronic airflow obstruction: relation to airway calibre. , 1991, Thorax.

[20]  A. Renzetti,et al.  Clinical interpretation of airway response to a bronchodilator: epidemiologic considerations. , 1989, The American review of respiratory disease.

[21]  W. Spitzer,et al.  Clinical interpretation of airway response to a bronchodilator. Epidemiologic considerations. , 1988, The American review of respiratory disease.

[22]  N. Anthonisen,et al.  Effect of dynamic airway compression on breathing pattern and respiratory sensation in severe chronic obstructive pulmonary disease. , 2015, The American review of respiratory disease.

[23]  H. D. Short,et al.  Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life. , 1987, The American review of respiratory disease.

[24]  Phillips Yy,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.

[25]  Anthonisen Nr,et al.  Bronchodilator response in chronic obstructive pulmonary disease. , 1986 .

[26]  A C Degraff,et al.  The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Influence of clinical diagnosis, spirometric, and anthropometric variables. , 1985, The American review of respiratory disease.

[27]  N. Anthonisen,et al.  Responses to large doses of salbutamol and theophylline in patients with chronic obstructive pulmonary disease. , 1985, The American review of respiratory disease.

[28]  J. Martin,et al.  Effect of panting frequency on the plethysmographic determination of thoracic gas volume in chronic obstructive pulmonary disease. , 2015, The American review of respiratory disease.

[29]  A. Grassino,et al.  Force reserve of the diaphragm in patients with chronic obstructive pulmonary disease. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

[30]  P E Pepe,et al.  Occult positive end-expiratory pressure in mechanically ventilated patients with airflow obstruction: the auto-PEEP effect. , 1982, The American review of respiratory disease.

[31]  J. Mead,et al.  Time dependence of maximum flow as an index of nonuniform emptying. , 1979, Journal of applied physiology: respiratory, environmental and exercise physiology.

[32]  P. Macklem,et al.  Significance of the relationship between lung recoil and maximum expiratory flow. , 1967, Journal of applied physiology.

[33]  R. Hyatt.  The interrelationships of pressure, flow, and volume during various respiratory maneuvers in normal and emphysematous subjects. , 2015, The American review of respiratory disease.

[34]  J. Goormaghtigh,et al.  The European Coal and Steel Community , 1956, Nature.